Scent of a vaccine
112 Citations•2021•
Frances E. Lund, Troy D. Randall
It seems surprising that only seven of the nearly 100 SARS-CoV-2 vaccines currently in clinical trials are delivered intranasally, but advantages of these vaccines include needle-free administration, delivery of antigen to the site of infection, and the elicitation of mucosal immunity in the respiratory tract.
Abstract
<jats:p>Intranasal vaccination should block SARS-CoV-2 transmission at the source</jats:p>